The science is slowly coming together to support the observations and results from clinical experience over the last 4 years. Dr. Beate Jaeger, Dr. Abdul Mannan Baig and colleagues have published a paper showing the reasons why H.E.L.P. Apheresis with Combination Therapy is such a revolutionising Long Covid and Post Vac treatment. Here’s a little summary for those who don’t like to read papers or simply can’t because of brainfog or cognitive dysfunction (Reading is difficult for you? Please see videos at the bottom). And please forgive my enthusiasm – Combination Therapy with H.E.L.P. Apheresis saved my life, my family and made me start the Apheresis Center – so don’t take my word for it, but maybe those of our patients: https://apheresiscenter.eu/testimonials
よろしく、マルクス
PS: If you are still curious after my little summary, you can find the full paper as a preprint here on Researchgate.
In the relentless battle against Long Covid and Post Vac, medical science has been trying with little success to find effective treatments to combat the virus and its lingering effects. But amidst this quest, a groundbreaking therapy has emerged: Combination Therapy with H.E.L.P. Apheresis. This revolutionary procedure is rewriting the playbook for managing COVID-19, Long COVID, and even the complications arising from post-COVID-19 vaccination syndrome. Let’s delve into the transformative potential of this breakthrough therapy and how it’s reshaping healthcare for the few lucky who have/had access.
Imagine a treatment that directly targets the root causes of COVID-19 complications, effectively clearing the bloodstream of harmful substances wreaking havoc on the body. That’s precisely what H.E.L.P. apheresis does. By filtering (to be more precise: removing by selective precipitation) the blood plasma, it removes clotting factors, spike proteins, toxins, cytokines, and detrimental lipids, offering a working treatment to patients battling the virus’s devastating effects.
How H.E.L.P. apheresis works: At the core of H.E.L.P. apheresis lies its ability to restore balance to the body’s internal environment. By lowering plasma levels of procoagulant factors and inflammatory agents, the therapy alleviates endothelial injury, hypercoagulability, and tissue damage – a trifecta of complications often encountered in severe Long Covid and Post Vac cases. What’s more, H.E.L.P. apheresis doesn’t stop there. It also tackles cardiovascular adverse effects, providing relief to those grappling with unforeseen complications.
Clinical triumphs of H.E.L.P. apheresis: The success stories of H.E.L.P. apheresis are nothing short of remarkable. Clinical testing has unveiled a slew of improvements in patients’ cognitive, functional, and autonomic outcomes post-treatment. Enhanced walking speed, cognitive performance, and stability in autonomic functions are just the tip of the iceberg.
Research microscopes reveal a world of transformation wrought by H.E.L.P. apheresis. Platelet hyperactivation and microclot-like structures, hallmarks of Long COVID and post-COVID-19 vaccination syndrome, dwindle post-treatment. Additionally, amyloid-like microclot structures, endothelial damage, and plasma protein misfolding – a trio of culprits fueling vessel obstruction and thickening – shrink in the face of this revolutionary therapy.
呼吸を楽に：H.E.L.P. アフェレーシスによる呼吸器系の健康回復：血液ガス分析では、アフェレーシス後に酸素濃度が上昇し、代謝パラメータが正常化するため、回復の絵が描かれる。呼吸困難と闘っている患者にとって、H.E.L.P. アフェレーシスは素晴らしい選択である。
Breaking down barriers: Biomarker revelations of H.E.L.P. apheresis: Serum biomarker analysis unveils a dramatic reduction in spike protein levels – a testament to the therapy’s prowess in dismantling the viral onslaught. Moreover, improvements in hypercoagulation and systemic inflammation markers signal a turning tide in the battle against the virus and its aftermath.
With each success story, we inch closer to a future where the virus holds less sway over our lives, thanks to the pioneering efforts of Combination Therapy with H.E.L.P. Apheresis and Early Treatment in case of Reinfection.
ビデオ
Part One: Microclots inside of human blood vessels – graphic animation and explanation
Microclots長期の入院生活、休暇後の傷害、慢性疾患における高活性化血小板、内皮障害、炎症。出典：cgtn.com
第二部：H.E.L.P. アフェレーシスでmicroclots 、炎症、病原体、スパイクタンパク質を除去する方法
microclots 、長期入院、休暇後の怪我、慢性疾患におけるその他の病原菌を除去する。出典：cgtn.com
